Australia's TGA has added mental health warnings to Ozempic and other GLP-1 drugs after reports of depression and suicidal ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

Australia’s drug regulator, Therapeutic Goods Administration, has issued a new safety warning for Ozempic and similar ...

The Australian Therapeutic Goods Administration (TGA) has updated its product warnings on the class of weight loss and ...

Patients taking these medicines should tell their health professional if they experience new or worsening depression, ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...

Australia’s drug regulator, the Therapeutic Goods Administration (TGA), has added two new safety warnings about mental health ...

The Australian Therapeutic Goods Administration (TGA) has updated and aligned safety warnings for people using GLP-1 and dual ...

FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...

Australia's Therapeutic Goods Administration has issued new safety warnings about mental health risks and contraception ...

Analysis has found a link between semaglutide use and suicidal thoughts but not all evidence supports these findings ...

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger ...